View in Other Languages

MMJ PhytoTech Ltd

ASX:MMJ ISIN:AU000000MMJ4

Phytotech Medical ASX:PYL

MMJ PhytoTech Limited (ASX:MMJ) is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024.

The Company controls operations across the entire medicinal cannabis value chain through its ~59% interest in TSX-V listed Harvest One Cannabis Inc (CVE:HVST) and its 100% interest in Israeli research and development subsidiary, PhytoTech Therapeutics Ltd, both of which are strategically located in favourable jurisdictions with supportive regulatory frameworks in place.

       

News

MMJ PhytoTech Ltd (ASX:MMJ) Phase 1 Clinical Trial Results Published in International Medical Journal

🕔11/16/2017 9:40:55 AM 750

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by MMJ's wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Ltd have been published.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One Operational Update

🕔11/15/2017 9:33:55 AM 780

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update on its medical and health division Satipharm AG.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Commits A$500,000 Cornerstone Investment in eSense-Lab Limited (ASX:ESE)

🕔11/14/2017 9:53:51 AM 1408

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has agreed to invest A$500,000 in ASX listed Israeli life sciences company eSense-Lab Limited (ASX:ESE).

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Quarterly Update and Appendix 4C

🕔11/1/2017 9:07:09 AM 1379

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 30 September 2017, together with its Appendix 4C.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Annual Report to Shareholders

🕔10/30/2017 8:31:44 AM 1129

MMJ PhytoTech Ltd (ASX:MMJ) provides the Company's 2017 Annual Report to shareholders.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One Operational Update

🕔10/16/2017 1:56:41 PM 1508

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an update on its wholly-owned subsidiary United Greeneries Ltd..

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Strategy Expansion

🕔10/10/2017 1:41:17 PM 1872

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the following update on the Company's strategic direction and proposed name change to "MMJ Capital Limited".

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Appointment of Chief Financial Officer

🕔6/14/2017 9:39:26 AM 2324

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to announce the appointment of Lisa Dea as Chief Financial Officer of the Company effective immediately. Ms. Dea has also been appointed CFO of Harvest One Cannabis Inc. (CVE:HVST), and replaces Mr Kwong Choo, who will be assuming a new role as Vice President Finance of Harvest One.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Investor Update Presentation

🕔5/31/2017 8:27:32 AM 1646

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the following investor update presentation, the purpose of which is to provide shareholders with an update on the Company's activities and strategic outlook following the completion of the Harvest One Transaction last month.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Receives Approval to Conduct Phase 2 Clinical Trial for Treatment of Multiple Sclerosis Symptoms

🕔5/15/2017 8:27:22 AM 3151

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited, has received Helsinki and Ministry of Health approvals for the conducting of its Phase 2 clinical study into the safety and efficacy of its PTL201 capsules in treating spasticity related symptoms of multiple sclerosis patients.

Read Full Article
###

43,680 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 465) (Last 30 Days: 1335) (Since Published: 32471) 

Markets ASX:MMJ

Company Data

    Headquarters
  • Suite 5 CPC, 145 Stirling Highway
    Nedlands WA 6009
    Australia
  • Telephone
  • +61-8-9389-3150 
  • Fax
  • +61-8-9389-3199 
  • Principal Sector
  • Ag Biotechnology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.mmjphytotech.com.au
  • E:
  • info@mmjphytotech.com.au

Company Reports

Presentations

Research Report

Quarterly Report

Social Media